Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04081623 · ClinicalTrials.gov registry record
Trans-abdominal Fetal Pulse Oximetry: Signal Integrity
A clinical trial, sponsored by Raydiant Oximetry.
- Terminated
- Registry status
- 9
- Enrollment target
NCT04081623: Clinical Trial study, sponsored by Raydiant Oximetry.
NCT04081623 is a clinical trial that was terminated before completion, run by Raydiant Oximetry. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04081623 was terminated before completion, sponsored by Raydiant Oximetry.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This project is set up to advance and integrate the established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters,
Interventions
- DEVICE Raydiant Oximetry Sensing System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-04-16 |
| Est. Completion | 2021-06-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04081623
The ClinicalTrials.gov registry entry for NCT04081623 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Raydiant Oximetry, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Raydiant Oximetry Sensing System is the first listed.
NCT04081623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04081623 about?
NCT04081623 is a clinical study titled "Trans-abdominal Fetal Pulse Oximetry: Signal Integrity". This project is set up to advance and integrate the established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters,
What is the current status of trial NCT04081623?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2019-04-16. Estimated completion is 2021-06-08.
What interventions are being tested in trial NCT04081623?
The interventions under investigation include: Raydiant Oximetry Sensing System (DEVICE).
Who is sponsoring clinical trial NCT04081623?
This trial is sponsored by Raydiant Oximetry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.